Opinion · 22 Oct 2024
Conference abstractPublished 2018
Temoporfin in cyclodextrin in liposome nanoparticles for tumor targeting
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Application of meta-tetra(hydroxyphenyl)chlorin (mTHPC), one of the most potent photosensitizer (PS), in the photodynamic therapy (PDT) of solid tumors encounters several complications originating from its poor solubility in aqueous medium. It requires low light doses and concentrations to be photoactive; however mTHPC aggregation results in reduced photodynamic activity, moderate selectivity and skin photo sensitivity. To improve the transport of mTHPC to target tissue and to strengthen its intra-tissue accumulation, the coupling of two independent delivery systems by encapsulating cyclodextrin/mTHPC inclusion complexes into liposomes to achieve drug-in-cyclodextrin-in-liposome (DCL) nanoparticles has been proposed. Liposomes offer an excellent opportunity to achieve selective drug targeting which is expected to optimize the pharmacokinetic parameters, prevent local irritation, and reduce drug toxicity. In its turn, cyclodextrinbased inclusion complexes have been already utilized as independent carriers for improvement of mTHPC delivery into the tumor tissue. Thus, the aim of this study was to evaluate the effect of DCLs on mTHPC distribution in vitro tumor models. After optimization of DCL composition, we choose TDCL double loaded nano construct including trimethyl- β-cyclodextrin/mTHPC inclusion complexes in the inner aqueous core and mTHPC molecules in lipid compartment. We studied mTHPC accumulation and localization in 3D tumor multicellular spheroid model. We demonstrated that the application of TDCL resulted in homogeneous distribution of mTHPC across the whole spheroid. Such efficient intra-tissue delivery is related to the extremely high binding of trimethyl- β-cyclodextrin to mTHPC that was confirmed by means of exclusion gel-chromatography.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.
More from this journal
The newest in International Journal of Drug Development and Research.
Opinion · 22 Oct 2024
From Monoclonal Antibodies to CAR-T Therapy: Trends and Transformations in Cancer Treatment
Perspective · 21 Oct 2024
Natural Products in Drug Discovery: From Traditional Remedies to Modern Medicines
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Drug Development and Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Ilya Yakavets”
- BylineArticles whose byline prints “Marie Millard”
- BylineArticles whose byline prints “Henri-Pierre Lassalle”
- BylineArticles whose byline prints “Lina Bezdetnaya”
- BylineArticles whose byline prints “Vladimir Zorin”
